SCHEMBL30544699

SCHEMBL30544699

CN1CCC[C@@H](c2cc3cn[nH]c(=O)c3cn2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.41
▸ NLRP3 Q96P20 1/20 0.37
▸ PRMT5 O14744 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35
▸ TLR8 Q9NR97 1/20 0.35
▸ TLR7 Q9NYK1 1/20 0.35
▸ MAP4K1 Q92918 1/20 0.34
▸ STAT3 P40763 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ MAP3K12 Q12852 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ ATR Q13535 1/20 0.34
▸ ATRIP Q8WXE1 1/20 0.34
▸ CCNT1 O60563 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ DRD2 P14416 2/20 0.33
▸ ERCC1 P07992 1/20 0.33
▸ ERCC4 Q92889 1/20 0.33
▸ TTBK1 Q5TCY1 1/20 0.33
▸ HTR2A P28223 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544681 1.00 MAP4K4 (0.41) MAP4K4NLRP3PRMT5TLR9TLR8
SCHEMBL30544664 1.00 MAP4K4 (0.41) MAP4K4NLRP3PRMT5TLR9TLR8
SCHEMBL30544688 0.93 PARP1 (0.34) MAP4K4STAT3PARP1BTK
SCHEMBL30544673 0.85 POLB (0.38) STAT3PARP1
SCHEMBL30544695 0.81 KCNH2 (0.45) PRMT5STAT3PARP1BTKDRD2
SCHEMBL30544661 0.80 KAT2B (0.44) MAP4K4NLRP3
SCHEMBL30544705 0.71 GSK3B (0.38) PARP1ATRATRIPKCNH2
SCHEMBL30544685 0.71 GSK3B (0.38) PARP1ATRATRIPKCNH2
SCHEMBL30544672 0.69 HTR3A (0.51) PARP1
SCHEMBL30544670 0.66 CHRNA7 (0.39) PARP1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635371-A Polycyclic pyridazinone derivative serving as SOS1 inhibitor, and preparation method and application thereof 苏州阿尔脉生物科技有限公司 2023-08-22 — — CN disclosed
Send feedback